Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PYPL vs MRNA✓SelectedUSD · MRNAPYPL vs MRNA performance historyLatest closeAs of-0.38%11/18
Stock and ETF performance explorer

PYPL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-29.3%
MRNA return
+794.5%
Excess return
-823.8%
Maximum drawdown
-87.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.4%-4.8%+4.5%-0.1%
7D-2.7%-20.9%+18.2%-1.2%
30D+2.4%-13.3%+15.7%+3.2%
3M-4.0%+212.6%-216.5%-16.3%
6M+31.2%+309.0%-277.9%+10.1%
YTD0.0%+567.3%-567.3%-21.3%
1Y-3.6%+689.7%-693.3%-25.8%
3Y+3.5%+157.4%-153.9%-13.5%
5Y-70.8%-21.7%-49.1%-73.8%
All-29.3%+794.5%-823.8%-38.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling